02075nas a2200229   4500008004100000022001400041245011200055210006900167260000800236300001100244490000900255520129500264653002501559653001401584653001401598653001301612653001901625100003601644700001601680700002601696856012301722       2023                        eng d  a0167-488900aTau aggregates improve the Purinergic receptor P2Y12-associated podosome rearrangements in microglial cells0 aTau aggregates improve the Purinergic receptor P2Y12associated p  cJUN  a1194770 v18703 a<p>
	Alzheimer's disease (AD) is a progressive neurodegenerative disease that is associated with protein misfolding, plaque accumulation, neuronal dysfunction, synaptic loss, and cognitive decline. The pathological cascade of AD includes the intracellular Tau hyperphosphorylation and its subsequent aggregation, extracellular Amyloid-&amp; beta; plaque formation and microglia-mediated neuroinflammation. The extracellular release of aggregated Tau is sensed by surveilling microglia through the involvement of various cell surface receptors. Among all, purinergic P2Y12R signaling is involved in microglial chemotaxis towards the damaged neurons. Microglial migration is highly linked with membrane-associated actin remodeling leading to the phagocytosis of extracellular Tau species. Here, we studied the formation of various actin structures such as podosome, lamellipodia and filopodia, in response to extracellular Tau monomers and aggregates. Microglial podosomes are colocalized with actin nucleator protein WASP, Arp2 and TKS5 adaptor protein during Tau-mediated migration. Moreover, the P2Y12 receptors were associated with F-actin-rich podosome structures, which signify the potential of Tau aggregates in microglial chemotaxis through the involvement of actin remodeling.</p>
10aAlzheimer `s disease10aFilopodia10amicroglia10aPodosome10aTau aggregates1 aChinnathambi, Subashchandrabose1 aDas, Rashmi1 aDesale, Smita, Eknath  uhttps://library.ncl.res.in/content/tau-aggregates-improve-purinergic-receptor-p2y12-associated-podosome-rearrangements